Simvastatin-induced lichen planus pemphigoides;Lichen plan pemphigoïde induit par la simvastatine

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 2 I, 2003, Pages 187-190

  Stoebner, P E ^a   Michot, C ^a   Ligeron, C ^a   Durand, L ^a   Meynadier, J ^a   Meunier, L ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CINNARIZINE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MOLSIDOMINE; RAMIPRIL; SIMVASTATIN;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CHEILITIS; DERMATOMYOSITIS; DRUG WITHDRAWAL; ECZEMA; HISTOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOFLUORESCENCE; LICHEN PLANUS; LICHEN PLANUS BULLOSUS; LICHENOID ERUPTION; LUPUS ERYTHEMATOSUS; MALE; PORPHYRIA CUTANEA TARDA; PRURITUS; URTICARIA; WESTERN BLOTTING;

ANTILIPEMIC AGENTS; BLOTTING, WESTERN; HUMANS; HYPERCHOLESTEROLEMIA; LICHEN PLANUS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; SIMVASTATIN;

EID: 0345269148     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sirtori CR. Pharmacology and mechanism of action of the new HMGCoA reductase inhibitors. Pharmacol Res 1990;22:555-63.
2. Roger D, Rolle F, Labrousse F, Brosset A, Bonnetblanc JM. Simvastatin-induced lichenoid drug eruption. Clin Exp Dermatol 1994;19:88-9.
3. Steyn K, Weich HFH, Vermaak WJH, Marais AD, Omar MAK, Van Gelder AL et al. A 6-month trial of simvastatin (HMG-CoA reductase inhibitors) in the treatment of hypercholesterolaemia. S Afr Med J 1991;79:639-45
4. Ziegler O, Drouin P. Safety, tolerability and efficacy of simvastatin and fenofibrate - A multicenter study. Cardiology 1990;77:50-7.
5. Krasovec M, Elsner P, Burg G. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology 1993;186:248-52.
6. Feldmann R, Mainetti C, Saurat JH. Skin lesions due to treatment with simvastatin (Zocor). Dermatology 1993;186:272.
7. Mehregan DR, Mehregan DA, Pakideh S. Cheilitis du to treatment with simvastatin. Cutis 1998;62:197-8.
8. Perrot JL, Guy C, Bour Guichenez G, Amigues O, Servoz J, Cambazard F. Porphyrie cutanée tardive induite par les inhibiteurs de l'HMG CoA reductase: simvastatine, pravastatine. Ann Dermatol Venereol 1994;121:817-9.
9. Khosla R, Butman AN, Hammer DF. Simvastatin-induced lupus erythematosus. South Med J 1998;91:873-4.
10. Ahmad A, Fletcher MT, Roy TM. Simvastatin-induced lupus-like syndrome. Term Med 2000;93:21-2.
11. Khattak FH, Morris IM, Branford WA. Simvastatin-associated dermatomyositis. Br J Rheumatol 1994;33:199.
12. Flageul B, Hassan F, Pinquier L, Blanchet-Bardon C, Dubertret L. Lichen pemphigoïde associée à une hepatite B chez un enfant. Ann Dermatol Venereol 1999;126:604-7.
13. Stevens SR, Griffiths CE, Anhalt GJ, Cooper KD. Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol 1993;129:866-9.
14. Miyagawa S, Ohi H, Muramatsu T, Okuchi T,.Shirai T, Sakamoto K. Lichen planus pemphigoides-like lesions induced by cinnarizine. Br J Dermatol 1985;112:607-13.
15. Flageul B, Foldes C, Wallach D, Vignon-Pennamen MD, Cottenot F. Captopril-induced lichen planus pemphigoides with pemphigus-like features. A case report. Dermatologica 1986;173:248-55.
16. Ogg GS, Bhogal BS, Hashimoto T, Coleman R, Barker JN. Ramiprilassociated lichen planus pemphigoides. Br J Dermatol 1997;136:412-4.
17. Boulinguez S, Béclane C, De Vencay P, Le Brun V, Sparsa A, Labrousse F, Bonnetblanc JM. Lichen plan pemphigoïde induit par le furosemide. Ann Dermatol Venereol 2000;127:4S169.
18. Godard W, Ingargiola F, Tavernier B, Justrabo E, Lambert D. Lichen plan pemphigoïde et puvathérapie. Ann Dermatol Venereol 1983;110:69-74.
19. Cognat T, Gayrard L, Adam C, Balmex B, Machado P, Nicolas JF, Moulin G. Lichen plan pemphigoïde. Ann Dermatol Venereol 1991;118:387-90.
20. Kuramoto N, Kishimoto S, Shibagaki R, Yasuno H. PUVA-induced lichen planus pemphigoides. Br J Dermatol 2000;142:509-12.
21. Perl S, Rappersberger K, Fodinger D, Anegg B, Honigsmann H, Ortel B. Bullous pemphigoid induced by PUVA therapy. Dermatology 1996;193:245-7.
22. Dowdy MJ, Nigra TP, Barth WF. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Arthritis Rheum 1989;32:343-6.
23. Murphy GM, Cronin E. Lichen planus pemphigoides. Clin Exp Dermatol 1989;14:322-4.
24. Mora RC, Nesbitt LT, Brantley JB. Lichen planus pemphigoides: clinical and immunofluorescent findings in four cases. J Am Acad Dermatol 1983;138:972-80.
25. Bouloc A, Vignon-Pennamen MD, Caux F, Teillac D, Wechsler J, Heller M et al. Lichen planus pemphigoides is a heterogeneous disease: a report of five cases studied by immunoelectron microscopy. Br J Dermatol 1998;138:972-80.
26. Tamada Y, Yokochi K, Nitta Y, Ikeya T, Hara K, Owaribe K. Lichen planus pemphigoides: identification of 180 kd hemidesmosome antigen. J Am Acad Dermatol 1995;32:883-7.
27. Hsu S, Ghohestani RF, Uitto J. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen). J Am Acad Dermatol 2000;42:136-41.
28. Yoon KH, Kim SC, Kang DS, Lee IJ. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens. Eur J Dermatol 2000;10:212-4
29. Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999;113:117-21.
30. Lang PG, Maize JC. Coexisting lichen planus and bullous pemphigoides or lichen planus pemphigoides? J Ann Acad Dermatol 1989;9:133-44.